End the guesswork of a colonoscopy.
The first real-time engine that turns endoscopic video into an objective severity quantification — precise, standardized, and reproducible across every country, site and scope.
Per-segment severity
scoredTrusted by clinical leaders & commercial partners
From a subjective look to a measured value.
Drag the divider across the same endoscopic frame — the Mucosal Intelligence layer finds the ulceration and returns an objective severity.
Subjective assessment
Mucosal Intelligence
Drag · or focus the handle and use arrow keys
The measurement layer for colonic disease.
Today, disease severity is scored by eye — observer-dependent, geography-dependent, irreproducible — one subjective number for an entire colon. We turn the video into a number, live. One engine serves the two sides of the market:
Accelerate IBD Clinical trials
Imprecise endpoints inflate trial size, slow recruitment, and weaken every treat-to-target decision. A ground-truth value decreases variability and tightens them.
- Objective, reproducible severity endpoints
- Faster, cleaner patient recruitment
- Central reading that travels across sites
Augment Clinical Decision
A small, recurring layer on every procedure — vendor-agnostic software that rides on top of the scopes clinicians already use.
- Runs on any scope, any vendor
- Consistent reads across operators
- Standardized monitoring over time
A ground-truth value that travels across sites and over time.
Our platform doesn't simply detect a polyp and stop. It measures severity per lesion and per segment, then standardizing it into a value that holds across sites and over time.
Guesswork is expensive. Precision pays back.
Remove the variability
One objective number replaces two doctors reading one scan two different ways.
Same scan, same score
Reproducible across operators, sites, and decades of repeat surveillance.
Tighter, quicker trials
Precise endpoints shrink trial size and accelerate recruitment timelines.
Expertise without headcount
A software layer that scales with the ~50M-and-growing procedures performed each year.
The people who design the trials are on our board.
Become the measurement standard for all of gastroenterology.
Start in IBD trials, where the pain and the money are. Pan-colon disease, scope by scope.
Founded in New York City · Paris · Basel — built for the global gastroenterology market.
Notes on the measurement layer for endoscopy.
Monthly. Research notes and product updates. No spam — unsubscribe anytime.